08.04.2020 Akers Biosciences Inc (aker)  Daily Analysis

08.04.2020 Akers Biosciences Inc (aker)  Daily Analysis

Akers today is trading at $5.70 it went up with $1.01 from $4.69 The main reason the share is continuing to go up is because of the announcement the company made stating that they are one step closer to coronavirus vaccine development. The company said their collaboration with Premas Biotech has made it possible for them to obtain all coronavirus antigens that have been selected for the vaccine candidate. The company is of the view that since they managed to identify all three antigens this will differentiate its vaccine candidate from others. According to Prabuddha Kundu, who is the co-founder and managing director at Premas Biotech, they are providing the immune system with three shots on goal which will help overcome the shortcoming of the vaccine being rendered non-efficacious. This, therefore, gave hope to the investors resulting in the share continues to go up.